Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2016-11-30
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sepsis group
The patients were admitted to the Jinling Hospital, who met the diagnosis of sepsis(Sepsis 3.0).
Antibiotics
In the sepsis group, antibiotics were used when needed.
Healthy control group
Healthy volunteers.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antibiotics
In the sepsis group, antibiotics were used when needed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy volunteers do not have serious illness.
Exclusion Criteria
* Patients give up treatments.
* Patients or volunteers withdrew from the study.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jinling Hospital, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jianan Ren
President of department of surgery, Jinling Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jianan Ren, MD
Role: PRINCIPAL_INVESTIGATOR
Jinling Hospital, Medical School of Nanjing University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jinling Hospital, Medical School of Nanjing University
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jianan Ren, MD
Role: primary
Yuan Li, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20161103
Identifier Type: -
Identifier Source: org_study_id